Encompass Health Corp EHC

Encompass Health Corp's clearest current development in the supplied evidence is an SEC 8-K dated 2026-05-15, which includes Exhibit 99.1, a press release dated May 14, 2026 with respect to a Notes Offering. The rail does not supply the coupon, maturity, proceeds or use of funds, so the financing story has to stay precise: there was an official Notes Offering disclosure, and the capital-structure details needed to weigh it fully are not parsed here.

The evidence identifies EHC as an SEC-reporting equity issuer and supplies financial statement facts from EDGAR, but it does not provide a product catalogue, facility count, customer breakdown, segment table or operational KPI set. That limit matters. The current file can speak firmly about reported revenue, income, cash, assets and liabilities, while avoiding invented claims about the service mix or operating footprint.

The latest parsed filed financials show revenue from contracts with customers, excluding assessed tax, of $1.59B for the 10-Q period ending 2026-03-31. Net income attributable to parent was $194.5M, diluted earnings per share were $1.93, and the weighted average diluted share count was 100.6M shares for the same 10-Q period. The balance sheet rail shows $7.31B of assets, $3.95B of liabilities, $2.52B of stockholders' equity attributable to parent, and $110.5M of cash and cash equivalents at carrying value, all for the 10-Q period ending 2026-03-31.

No TradingView route, chart source or market-level evidence is supplied, so this file does not discuss candles, support, resistance, moving averages or price action. The usable source route is the SEC rail: the EDGAR filing index, the SEC submissions JSON, companyfacts JSON, the May 2026 8-K filings, Form 4 filings, and Form 144 notices. That makes the mechanism a disclosure story rather than a chart story.

The recent public-paper trail also includes an EHC 8-K dated 2026-06-01, Form 4 filings dated 2026-05-18 and 2026-05-12, and Form 144 notices dated 2026-05-15 and 2026-05-11. The supplied evidence names the forms and dates but does not parse the underlying resolutions, insider names, transaction amounts or planned-sale quantities, so the correct conclusion is not suspicion or comfort. It is that the current Encompass Health file needs the detailed exhibits and ownership tables read before the next layer can be written.

The weight of the evidence is therefore narrow but useful: EHC has a fresh official financing-related 8-K, recent ownership and proposed-sale filings, and a latest 10-Q financial snapshot with $1.59B of revenue, $194.5M of parent-attributable net income, and $110.5M of cash against $3.95B of liabilities. That is enough to frame the daily story without pretending the rail has supplied operational colour it has not.